-
Nov 6, 2017, 15:25 PM
Video on Demand, Communications, Membership and more...
Full story
-
Oct 2, 2017, 08:28 AM
Full story
-
Jul 3, 2017, 09:43 AM
The impact factor for Pharmaceutical Statistics is 1.276 for 2016, improving from 1.235 in the previous year.
Full story
-
Jul 3, 2017, 07:58 AM
Robert Cuffe, recent Chair of PSI, is to take up the position of head of statistics at BBC News.
Full story
-
Jun 13, 2017, 07:32 AM
In the March/April 2017 issue of Pharmaceutical Statistics, EFSPI/PSI's Special Interest Group (SIG) for Modelling and Simulation published a Proposed Best Practice for Projects Involving Modelling and Simulation. The Board of PSI has now formally endorsed the Best Practice.
Full story
-
May 25, 2017, 15:02 PM
We are very pleased to announce that the winner of the 2017 Statistical Excellence in the Pharmaceutical Industry Award goes to Dr Michael O’Kelly, principal scientific advisor at QuintilesIMS.
Full story
-
May 25, 2017, 08:35 AM
The 2017 PSI conference was held in London last week with a record attendance and fantastic scientific content.
For those of you who missed the Close of the Conference, Anna Berglind from AstraZeneca presented the winners of this year's Poster Prize. We had 53 posters, and the quality of posters was very high.
Full story
-
Apr 10, 2017, 12:57 PM
One of the motions at this year's AGM is to change the membership categories in order to make PSI more inclusive. Our industry and roles are changing and PSI needs to move with these changes. We therefore plan to make PSI more inclusive and open to new members.
Full story
-
Apr 4, 2017, 07:40 AM
Full story
-
Feb 14, 2017, 09:21 AM
Nominations are being sought for the 2017 Award for Statistical Excellence in the Pharmaceutical Industry.
Full story
-
Jan 13, 2017, 10:27 AM
PSI welcomes Jorgen Seldrup as the new Editor-in-Chief.
Full story
-
Oct 31, 2016, 15:54 PM
The ACE Project aims to develop a consensus driven reporting guidance tailored for ADs in the form of a CONSORT extension. We hope this will enhance transparency, credibility, reproducibility, and replicability of adaptive trials. The hope would be to facilitate uptake of ADs in clinical trials research when appropriate.
Full story
-
Oct 28, 2016, 14:15 PM
Full story
-
Sep 28, 2016, 10:39 AM
The purpose of this document is to outline general principles for the planning and design of multiregional clinical trials with the aim of increasing their acceptability in global regulatory submissions.
Full story
-
Sep 28, 2016, 10:38 AM
The purpose of this guideline is to provide guidance on all stages of clinical drug development for the treatment of malignancies, including drug resistance modifiers or normal tissue protective compounds. Supportive measures such as anti-emetics and haematopoietic growth factors, however, are covered by separate guidelines.
Full story
-
Jul 14, 2016, 10:58 AM
Full story
-
Jun 28, 2016, 14:47 PM
The RSS Statistics in Africa appeal has just been launched!
Full story
-
Jun 3, 2016, 11:13 AM
PCMG and PSI created a joint working party to develop metrics that relate specifically to the statistical and programming activities of both sponsors and CROs in clinical trials.
Full story
-
May 6, 2016, 09:37 AM
The PSI TOXSIG held its last workshop in October 2015 and hope to hold our next workshop in March 2017, provisional dates of 14th and 15th.
Full story
-
May 5, 2016, 14:05 PM
CORE (Clarity and Openness in Reporting: E3-based) Reference is now available as an open-access resource
Full story